PROSOMNUS Stock Price, News & Analysis

OSAP OTC

Company Description

PROSOMNUS (OTC: OSAP) is a publicly traded company.

OSAP stock has declined 99.8% over the past year.

This page provides a comprehensive overview of OSAP stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-99.81%

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

PROSOMNUS (OSAP) stock. Over the past 12 months, the stock has lost 99.8%.

Latest News

View All

3 days ago

—

ProSomnus® Receives FDA Class II Clearance for RPMO2 OSA Device

August 7, 2024

—

ProSomnus® Sleep Technologies Announces Record Revenues as it Emerges from Reorganization

May 30, 2024

-15.15%

ProSomnus Contributes Two Scientific Abstracts for Presentation at SLEEP 2024, A Joint Meeting of the American Academy of Sleep Medicine and the Sleep Research Society

May 16, 2024

+48.88%

ProSomnus Announces Strong First Quarter 2024 Revenue Growth

earnings

May 13, 2024

-0.69%

ProSomnus Contributes Two Scientific Abstracts Accepted for Presentation at the 2024 American Academy of Dental Sleep Medicine Annual Meeting

May 9, 2024

+85.90%

Four Independent Scientific Abstracts at the American Academy of Dental Sleep Medicine Annual Meeting Feature ProSomnus Intraoral Medical Devices

PROSOMNUS has 7 recent news articles, with the latest published 3 days ago. Of the recent coverage, 2 articles coincided with positive price movement and 3 with negative movement. Key topics include earnings. View all OSAP news →

SEC Filings

View All

No SEC filings available for OSAP.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months